HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemotherapy in esophageal cancer.

Abstract
Esophageal cancer is a virulent malignancy, with the conventional approach of surgery or radiation therapy offering patients only a small chance for long-term disease-free survival. The frequent early systemic dissemination of disease has prompted an ongoing interest in the study of chemotherapy. A broad range of antitumor agents have been studied which demonstrate moderate antitumor activity. A number of combination chemotherapy regimens, mainly cisplatin-based, have been studied, which have consistently greater antitumor activity in local regional disease compared with metastatic disease. The use of preoperative chemotherapy in the surgical treatment of the disease remains investigational. Results from clinical trials comparing radiation therapy alone with concurrent radiation and chemotherapy demonstrate a survival benefit for the use of a combination of concurrent chemotherapy and radiation compared to radiation therapy alone. However, current studies with conventional chemotherapy, radiation and surgery are likely to impart at best a modest to moderate improvement in the treatment of esophageal carcinoma. The priority in chemotherapy trials, therefore, remains the identification of new active chemotherapy agents. The search for novel therapeutic approaches, exploiting advances in understanding of the molecular biology of the disease, continues.
AuthorsD H Ilson, D P Kelson
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 4 Issue 3 Pg. 287-99 (Jun 1993) ISSN: 0959-4973 [Print] England
PMID8358056 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
Topics
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Clinical Trials as Topic
  • Esophageal Neoplasms (drug therapy)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: